Sphingolipids in mitochondria

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1862, Issue 1, 2017, Pages 56-68

  Hernández Corbacho, María José ^a   Salama, Mohamed F ^a,b   Canals, Daniel ^a   Senkal, Can E ^a   Obeid, Lina M ^a,c  

^a STONY BROOK UNIVERSITY   (United States)

^b Mansoura University   (Egypt)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cancer; Ceramide; Mitochondrial apoptosis; Mitophagy; Sphingolipid metabolism

Indexed keywords

3 KETODIHYDROSPHINGOSINE REDUCTASE; CERAMIDASE; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; CERAMIDE KINASE; CERAMIDE SYNTHASE; DIHYDROCERAMIDE DESATURASE; GALACTOSYLCERAMIDASE; GALACTOSYLCERAMIDE; GALACTOSYLTRANSFERASE; GLUCOSYLCERAMIDASE; GLUCOSYLCERAMIDE; NEUTRAL CERAMIDASE; SERINE PALMITOYLTRANSFERASE; SPHINGANINE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE LYASE; SPHINGOSINE KINASE; SYNTHETASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; CANCER CELL; CATABOLISM; CHEMICAL STRUCTURE; DIABETES MELLITUS; HUMAN; MITOCHONDRION; MITOPHAGY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REPERFUSION INJURY; REVIEW; SPHINGOLIPID METABOLISM; ANIMAL; CELL MEMBRANE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL MEMBRANE; CERAMIDES; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; SIGNAL TRANSDUCTION; SPHINGOLIPIDS;

EID: 84997294308     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2016.09.019     Document Type: Review

References (148)

1. [1] Goni, F.M., Alonso, A., Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim. Biophys. Acta 1758 (2006), 1902–1921.
2. [2] Simons, K., Ikonen, E., Functional rafts in cell membranes. Nature 387 (1997), 569–572.
3. [3] Ando, J., Kinoshita, M., Cui, J., Yamakoshi, H., Dodo, K., Fujita, K., Murata, M., Sodeoka, M., Sphingomyelin distribution in lipid rafts of artificial monolayer membranes visualized by Raman microscopy. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 4558–4563.
4. [4] Hannun, Y.A., Obeid, L.M., Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9 (2008), 139–150.
5. [5] Canals, D., Jenkins, R.W., Roddy, P., Hernandez-Corbacho, M.J., Obeid, L.M., Hannun, Y.A., Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane. J. Biol. Chem. 285 (2010), 32476–32485.
6. [6] Lopez-Montero, I., Rodriguez, N., Cribier, S., Pohl, A., Velez, M., Devaux, P.F., Rapid transbilayer movement of ceramides in phospholipid vesicles and in human erythrocytes. J. Biol. Chem. 280 (2005), 25811–25819.
7. [7] Frickenhaus, S., Heinrich, R., Kinetic and thermodynamic aspects of lipid translocation in biological membranes. Biophys. J. 76 (1999), 1293–1309.
8. [8] Mullen, T.D., Hannun, Y.A., Obeid, L.M., Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem. J. 441 (2012), 789–802.
9. [9] Senkal, C.E., Ponnusamy, S., Rossi, M.J., Bialewski, J., Sinha, D., Jiang, J.C., Jazwinski, S.M., Hannun, Y.A., Ogretmen, B., Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol. Cancer Ther. 6 (2007), 712–722.
10. [10] Bionda, C., Portoukalian, J., Schmitt, D., Rodriguez-Lafrasse, C., Ardail, D., Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?. Biochem. J. 382 (2004), 527–533.
11. [11] El Bawab, S., Roddy, P., Qian, T., Bielawska, A., Lemasters, J.J., Hannun, Y.A., Molecular cloning and characterization of a human mitochondrial ceramidase. J. Biol. Chem. 275 (2000), 21508–21513.
12. [12] Wu, B.X., Rajagopalan, V., Roddy, P.L., Clarke, C.J., Hannun, Y.A., Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5. J. Biol. Chem. 285 (2010), 17993–18002.
13. [13] Birbes, H., El Bawab, S., Hannun, Y.A., Obeid, L.M., Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J. 15 (2001), 2669–2679.
14. [14] Hornemann, T., Richard, S., Rutti, M.F., Wei, Y., von Eckardstein, A., Cloning and initial characterization of a new subunit for mammalian serine-palmitoyltransferase. J. Biol. Chem. 281 (2006), 37275–37281.
15. [15] Hornemann, T., Penno, A., Rutti, M.F., Ernst, D., Kivrak-Pfiffner, F., Rohrer, L., von Eckardstein, A., The SPTLC3 subunit of serine palmitoyltransferase generates short chain sphingoid bases. J. Biol. Chem. 284 (2009), 26322–26330.
16. [16] Dawkins, J.L., Hulme, D.J., Brahmbhatt, S.B., Auer-Grumbach, M., Nicholson, G.A., Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat. Genet. 27 (2001), 309–312.
17. [17] Murphy, S.M., Ernst, D., Wei, Y., Laura, M., Liu, Y.T., Polke, J., Blake, J., Winer, J., Houlden, H., Hornemann, T., Reilly, M.M., Hereditary sensory and autonomic neuropathy type 1 (HSANI) caused by a novel mutation in SPTLC2. Neurology 80 (2013), 2106–2111.
18. [18] Beeler, T., Bacikova, D., Gable, K., Hopkins, L., Johnson, C., Slife, H., Dunn, T., The Saccharomyces cerevisiae TSC10/YBR265w gene encoding 3-ketosphinganine reductase is identified in a screen for temperature-sensitive suppressors of the Ca2 +-sensitive csg2Delta mutant. J. Biol. Chem. 273 (1998), 30688–30694.
19. [19] Kihara, A., Igarashi, Y., FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an active site that faces the cytosolic side of the endoplasmic reticulum membrane. J. Biol. Chem. 279 (2004), 49243–49250.
20. [20] Ogretmen, B., Pettus, B.J., Rossi, M.J., Wood, R., Usta, J., Szulc, Z., Bielawska, A., Obeid, L.M., Hannun, Y.A., Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. Role for endogenous ceramide in mediating the action of exogenous ceramide. J. Biol. Chem. 277 (2002), 12960–12969.
21. [21] Savile, C.K., Fabrias, G., Buist, P.H., Dihydroceramide delta(4) desaturase initiates substrate oxidation at C-4. J. Am. Chem. Soc. 123 (2001), 4382–4385.
22. [22] Beauchamp, E., Goenaga, D., Le Bloc'h, J., Catheline, D., Legrand, P., Rioux, V., Myristic acid increases the activity of dihydroceramide Delta4-desaturase 1 through its N-terminal myristoylation. Biochimie 89 (2007), 1553–1561.
23. [23] Holland, W.L., Brozinick, J.T., Wang, L.P., Hawkins, E.D., Sargent, K.M., Liu, Y., Narra, K., Hoehn, K.L., Knotts, T.A., Siesky, A., Nelson, D.H., Karathanasis, S.K., Fontenot, G.K., Birnbaum, M.J., Summers, S.A., Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5 (2007), 167–179.
24. [24] Kudo, N., Kumagai, K., Tomishige, N., Yamaji, T., Wakatsuki, S., Nishijima, M., Hanada, K., Kato, R., Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 488–493.
25. [25] Villani, M., Subathra, M., Im, Y.B., Choi, Y., Signorelli, P., Del Poeta, M., Luberto, C., Sphingomyelin synthases regulate production of diacylglycerol at the Golgi. Biochem. J. 414 (2008), 31–41.
26. [26] Vacaru, A.M., Tafesse, F.G., Ternes, P., Kondylis, V., Hermansson, M., Brouwers, J.F., Somerharju, P., Rabouille, C., Holthuis, J.C., Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER. J. Cell Biol. 185 (2009), 1013–1027.
27. [27] Jennemann, R., Sandhoff, R., Langbein, L., Kaden, S., Rothermel, U., Gallala, H., Sandhoff, K., Wiegandt, H., Grone, H.J., Integrity and barrier function of the epidermis critically depend on glucosylceramide synthesis. J. Biol. Chem. 282 (2007), 3083–3094.
28. [28] Liu, Y.Y., Hill, R.A., Li, Y.T., Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance. Adv. Cancer Res. 117 (2013), 59–89.
29. [29] Sabourdy, F., Kedjouar, B., Sorli, S.C., Colie, S., Milhas, D., Salma, Y., Levade, T., Functions of sphingolipid metabolism in mammals—lessons from genetic defects. Biochim. Biophys. Acta 1781 (2008), 145–183.
30. [30] Lamour, N.F., Stahelin, R.V., Wijesinghe, D.S., Maceyka, M., Wang, E., Allegood, J.C., Merrill, A.H. Jr., Cho, W., Chalfant, C.E., Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis. J. Lipid Res. 48 (2007), 1293–1304.
31. [31] Mitsutake, S., Yokose, U., Kato, M., Matsuoka, I., Yoo, J.M., Kim, T.J., Yoo, H.S., Fujimoto, K., Ando, Y., Sugiura, M., Kohama, T., Igarashi, Y., The generation and behavioral analysis of ceramide kinase-null mice, indicating a function in cerebellar Purkinje cells. Biochem. Biophys. Res. Commun. 363 (2007), 519–524.
32. [32] Graf, C., Zemann, B., Rovina, P., Urtz, N., Schanzer, A., Reuschel, R., Mechtcheriakova, D., Muller, M., Fischer, E., Reichel, C., Huber, S., Dawson, J., Meingassner, J.G., Billich, A., Niwa, S., Badegruber, R., Van Veldhoven, P.P., Kinzel, B., Baumruker, T., Bornancin, F., Neutropenia with impaired immune response to Streptococcus pneumoniae in ceramide kinase-deficient mice. J. Immunol. 180 (2008), 3457–3466.
33. [33] Presa, N., Gomez-Larrauri, A., Rivera, I.G., Ordonez, M., Trueba, M., Gomez-Munoz, A., Regulation of cell migration and inflammation by ceramide 1-phosphate. Biochim. Biophys. Acta 1861 (2016), 402–409.
34. [34] Zhang, Y., Cheng, Y., Hansen, G.H., Niels-Christiansen, L.L., Koentgen, F., Ohlsson, L., Nilsson, A., Duan, R.D., Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice. J. Lipid Res. 52 (2011), 771–781.
35. [35] Rhein, C., Reichel, M., Muhle, C., Rotter, A., Schwab, S.G., Kornhuber, J., Secretion of acid sphingomyelinase is affected by its polymorphic signal peptide. Cell. Physiol. Biochem. 34 (2014), 1385–1401.
36. [36] Jenkins, R.W., Canals, D., Hannun, Y.A., Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell. Signal. 21 (2009), 836–846.
37. [37] Tani, M., Hannun, Y.A., Analysis of membrane topology of neutral sphingomyelinase 2. FEBS Lett. 581 (2007), 1323–1328.
38. [38] Clarke, C.J., Truong, T.G., Hannun, Y.A., Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2. J. Biol. Chem. 282 (2007), 1384–1396.
39. [39] Park, J.H., Schuchman, E.H., Acid ceramidase and human disease. Biochim. Biophys. Acta 1758 (2006), 2133–2138.
40. [40] Ito, M., Okino, N., Tani, M., New insight into the structure, reaction mechanism, and biological functions of neutral ceramidase. Biochim. Biophys. Acta 1841 (2014), 682–691.
41. [41] Ohlsson, L., Palmberg, C., Duan, R.D., Olsson, M., Bergman, T., Nilsson, A., Purification and characterization of human intestinal neutral ceramidase. Biochimie 89 (2007), 950–960.
42. [42] Snider, A.J., Wu, B.X., Jenkins, R.W., Sticca, J.A., Kawamori, T., Hannun, Y.A., Obeid, L.M., Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. Prostaglandins Other Lipid Mediat. 99 (2012), 124–130.
43. [43] Sun, W., Xu, R., Hu, W., Jin, J., Crellin, H.A., Bielawski, J., Szulc, Z.M., Thiers, B.H., Obeid, L.M., Mao, C., Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes. J. Invest. Dermatol. 128 (2008), 389–397.
44. [44] Mao, C., Xu, R., Szulc, Z.M., Bielawski, J., Becker, K.P., Bielawska, A., Galadari, S.H., Hu, W., Obeid, L.M., Cloning and characterization of a mouse endoplasmic reticulum alkaline ceramidase: an enzyme that preferentially regulates metabolism of very long chain ceramides. J. Biol. Chem. 278 (2003), 31184–31191.
45. [45] Sun, W., Hu, W., Xu, R., Jin, J., Szulc, Z.M., Zhang, G., Galadari, S.H., Obeid, L.M., Mao, C., Alkaline ceramidase 2 regulates beta1 integrin maturation and cell adhesion. FASEB J. 23 (2009), 656–666.
46. [46] Hu, W., Xu, R., Sun, W., Szulc, Z.M., Bielawski, J., Obeid, L.M., Mao, C., Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis. J. Biol. Chem. 285 (2010), 7964–7976.
47. [47] Stahelin, R.V., Hwang, J.H., Kim, J.H., Park, Z.Y., Johnson, K.R., Obeid, L.M., Cho, W., The mechanism of membrane targeting of human sphingosine kinase 1. J. Biol. Chem. 280 (2005), 43030–43038.
48. [48] Wang, Z., Min, X., Xiao, S.H., Johnstone, S., Romanow, W., Meininger, D., Xu, H., Liu, J., Dai, J., An, S., Thibault, S., Walker, N., Molecular basis of sphingosine kinase 1 substrate recognition and catalysis. Structure 21 (2013), 798–809.
49. [49] Maceyka, M., Sankala, H., Hait, N.C., Le Stunff, H., Liu, H., Toman, R., Collier, C., Zhang, M., Satin, L.S., Merrill, A.H. Jr., Milstien, S., Spiegel, S., SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem. 280 (2005), 37118–37129.
50. [50] Hait, N.C., Allegood, J., Maceyka, M., Strub, G.M., Harikumar, K.B., Singh, S.K., Luo, C., Marmorstein, R., Kordula, T., Milstien, S., Spiegel, S., Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325 (2009), 1254–1257.
51. [51] Mandala, S.M., Thornton, R., Galve-Roperh, I., Poulton, S., Peterson, C., Olivera, A., Bergstrom, J., Kurtz, M.B., Spiegel, S., Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 7859–7864.
52. [52] Ogawa, C., Kihara, A., Gokoh, M., Igarashi, Y., Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2. J. Biol. Chem. 278 (2003), 1268–1272.
53. [53] Mao, C., Obeid, L.M., Yeast sphingosine-1-phosphate phosphatases: assay, expression, deletion, purification, and cellular localization by GFP tagging. Methods Enzymol. 311 (2000), 223–232.
54. [54] Johnson, K.R., Johnson, K.Y., Becker, K.P., Bielawski, J., Mao, C., Obeid, L.M., Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. J. Biol. Chem. 278 (2003), 34541–34547.
55. [55] Long, J., Darroch, P., Wan, K.F., Kong, K.C., Ktistakis, N., Pyne, N.J., Pyne, S., Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. Biochem. J. 391 (2005), 25–32.
56. [56] Le Stunff, H., Giussani, P., Maceyka, M., Lepine, S., Milstien, S., Spiegel, S., Recycling of sphingosine is regulated by the concerted actions of sphingosine-1-phosphate phosphohydrolase 1 and sphingosine kinase 2. J. Biol. Chem. 282 (2007), 34372–34380.
57. [57] Fyrst, H., Saba, J.D., Sphingosine-1-phosphate lyase in development and disease: sphingolipid metabolism takes flight. Biochim. Biophys. Acta 1781 (2008), 448–458.
58. [58] Aguilar, A., Saba, J.D., Truth and consequences of sphingosine-1-phosphate lyase. Adv. Biol. Regul. 52 (2012), 17–30.
59. [59] Allende, M.L., Bektas, M., Lee, B.G., Bonifacino, E., Kang, J., Tuymetova, G., Chen, W., Saba, J.D., Proia, R.L., Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. J. Biol. Chem. 286 (2011), 7348–7358.
60. [60] Degagne, E., Pandurangan, A., Bandhuvula, P., Kumar, A., Eltanawy, A., Zhang, M., Yoshinaga, Y., Nefedov, M., de Jong, P.J., Fong, L.G., Young, S.G., Bittman, R., Ahmedi, Y., Saba, J.D., Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. J. Clin. Invest. 124 (2014), 5368–5384.
61. [61] Deng, X., Yin, X., Allan, R., Lu, D.D., Maurer, C.W., Haimovitz-Friedman, A., Fuks, Z., Shaham, S., Kolesnick, R., Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans. Science 322 (2008), 110–115.
62. [62] Park, J.W., Park, W.J., Futerman, A.H., Ceramide synthases as potential targets for therapeutic intervention in human diseases. Biochim. Biophys. Acta 1841 (2014), 671–681.
63. [63] Hernandez-Corbacho, M.J., Canals, D., Adada, M.M., Liu, M., Senkal, C.E., Yi, J.K., Mao, C., Luberto, C., Hannun, Y.A., Obeid, L.M., Tumor necrosis factor-alpha (TNFalpha)-induced ceramide generation via ceramide synthases regulates loss of focal adhesion kinase (FAK) and programmed cell death. J. Biol. Chem. 290 (2015), 25356–25373.
64. [64] Yu, J., Novgorodov, S.A., Chudakova, D., Zhu, H., Bielawska, A., Bielawski, J., Obeid, L.M., Kindy, M.S., Gudz, T.I., JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction. J. Biol. Chem. 282 (2007), 25940–25949.
65. [65] Mesicek, J., Lee, H., Feldman, T., Jiang, X., Skobeleva, A., Berdyshev, E.V., Haimovitz-Friedman, A., Fuks, Z., Kolesnick, R., Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell. Signal. 22 (2010), 1300–1307.
66. [66] Novgorodov, S.A., Chudakova, D.A., Wheeler, B.W., Bielawski, J., Kindy, M.S., Obeid, L.M., Gudz, T.I., Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2 + loading capacity and promotes apoptosis. J. Biol. Chem. 286 (2011), 4644–4658.
67. [67] Yabu, T., Shimuzu, A., Yamashita, M., A novel mitochondrial sphingomyelinase in zebrafish cells. J. Biol. Chem. 284 (2009), 20349–20363.
68. [68] Kitagaki, H., Cowart, L.A., Matmati, N., Vaena de Avalos, S., Novgorodov, S.A., Zeidan, Y.H., Bielawski, J., Obeid, L.M., Hannun, Y.A., Isc1 regulates sphingolipid metabolism in yeast mitochondria. Biochim. Biophys. Acta 1768 (2007), 2849–2861.
69. [69] Rajagopalan, V., Canals, D., Luberto, C., Snider, J., Voelkel-Johnson, C., Obeid, L.M., Hannun, Y.A., Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization. Biochim. Biophys. Acta 1850 (2015), 628–639.
70. [70] Novgorodov, S.A., Wu, B.X., Gudz, T.I., Bielawski, J., Ovchinnikova, T.V., Hannun, Y.A., Obeid, L.M., Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA. J. Biol. Chem. 286 (2011), 25352–25362.
71. [71] Stiban, J., Caputo, L., Colombini, M., Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins. J. Lipid Res. 49 (2008), 625–634.
72. [72] Obeid, L.M., Linardic, C.M., Karolak, L.A., Hannun, Y.A., Programmed cell death induced by ceramide. Science 259 (1993), 1769–1771.
73. [73] Mullen, T.D., Obeid, L.M., Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anti Cancer Agents Med. Chem. 12 (2012), 340–363.
74. [74] Ogretmen, B., Hannun, Y.A., Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4 (2004), 604–616.
75. [75] Dbaibo, G.S., Pushkareva, M.Y., Jayadev, S., Schwarz, J.K., Horowitz, J.M., Obeid, L.M., Hannun, Y.A., Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 1347–1351.
76. [76] Ruvolo, P.P., Deng, X., Ito, T., Carr, B.K., May, W.S., Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. 274 (1999), 20296–20300.
77. [77] Xin, M., Deng, X., Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation. J. Biol. Chem. 281 (2006), 18859–18867.
78. [78] Young, M.M., Kester, M., Wang, H.G., Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J. Lipid Res. 54 (2013), 5–19.
79. [79] Birbes, H., Luberto, C., Hsu, Y.T., El Bawab, S., Hannun, Y.A., Obeid, L.M., A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria. Biochem. J. 386 (2005), 445–451.
80. [80] Ganesan, V., Perera, M.N., Colombini, D., Datskovskiy, D., Chadha, K., Colombini, M., Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane. Apoptosis 15 (2010), 553–562.
81. [81] Siskind, L.J., Kolesnick, R.N., Colombini, M., Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion 6 (2006), 118–125.
82. [82] Lee, H., Rotolo, J.A., Mesicek, J., Penate-Medina, T., Rimner, A., Liao, W.C., Yin, X., Ragupathi, G., Ehleiter, D., Gulbins, E., Zhai, D., Reed, J.C., Haimovitz-Friedman, A., Fuks, Z., Kolesnick, R., Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation. PLoS One, 6, 2011, e19783.
83. [83] Belaud-Rotureau, M.A., Leducq, N., Macouillard Poulletier de Gannes, F., Diolez, P., Lacoste, L., Lacombe, F., Bernard, P., Belloc, F., Early transitory rise in intracellular pH leads to Bax conformation change during ceramide-induced apoptosis. Apoptosis 5 (2000), 551–560.
84. [84] Kong, J.Y., Klassen, S.S., Rabkin, S.W., Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis. Mol. Cell. Biochem. 278 (2005), 39–51.
85. [85] Kim, H.J., Oh, J.E., Kim, S.W., Chun, Y.J., Kim, M.Y., Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells. Cancer Lett. 260 (2008), 88–95.
86. [86] Lin, C.F., Chen, C.L., Chiang, C.W., Jan, M.S., Huang, W.C., Lin, Y.S., GSK-3beta acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis. J. Cell Sci. 120 (2007), 2935–2943.
87. [87] De Stefanis, D., Reffo, P., Bonelli, G., Baccino, F.M., Sala, G., Ghidoni, R., Codogno, P., Isidoro, C., Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells. Biol. Chem. 383 (2002), 989–999.
88. [88] Heinrich, M., Neumeyer, J., Jakob, M., Hallas, C., Tchikov, V., Winoto-Morbach, S., Wickel, M., Schneider-Brachert, W., Trauzold, A., Hethke, A., Schutze, S., Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ. 11 (2004), 550–563.
89. [89] Darios, F., Lambeng, N., Troadec, J.D., Michel, P.P., Ruberg, M., Ceramide increases mitochondrial free calcium levels via caspase 8 and Bid: role in initiation of cell death. J. Neurochem. 84 (2003), 643–654.
90. [90] Yuan, H., Williams, S.D., Adachi, S., Oltersdorf, T., Gottlieb, R.A., Cytochrome c dissociation and release from mitochondria by truncated Bid and ceramide. Mitochondrion 2 (2003), 237–244.
91. [91] Sumitomo, M., Ohba, M., Asakuma, J., Asano, T., Kuroki, T., Asano, T., Hayakawa, M., Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J. Clin. Invest. 109 (2002), 827–836.
92. [92] Sawada, M., Nakashima, S., Banno, Y., Yamakawa, H., Takenaka, K., Shinoda, J., Nishimura, Y., Sakai, N., Nozawa, Y., Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Oncogene 19 (2000), 3508–3520.
93. [93] von Haefen, C., Wieder, T., Gillissen, B., Starck, L., Graupner, V., Dorken, B., Daniel, P.T., Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 21 (2002), 4009–4019.
94. [94] Siskind, L.J., Colombini, M., The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis. J. Biol. Chem. 275 (2000), 38640–38644.
95. [95] Stiban, J., Fistere, D., Colombini, M., Dihydroceramide hinders ceramide channel formation: implications on apoptosis. Apoptosis 11 (2006), 773–780.
96. [96] Elrick, M.J., Fluss, S., Colombini, M., Sphingosine, a product of ceramide hydrolysis, influences the formation of ceramide channels. Biophys. J. 91 (2006), 1749–1756.
97. [97] Siskind, L.J., Feinstein, L., Yu, T., Davis, J.S., Jones, D., Choi, J., Zuckerman, J.E., Tan, W., Hill, R.B., Hardwick, J.M., Colombini, M., Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels. J. Biol. Chem. 283 (2008), 6622–6630.
98. [98] Beverly, L.J., Howell, L.A., Hernandez-Corbacho, M., Casson, L., Chipuk, J.E., Siskind, L.J., BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins. Biochem. J. 452 (2013), 111–119.
99. [99] Cuvillier, O., Sphingosine in apoptosis signaling. Biochim. Biophys. Acta 1585 (2002), 153–162.
100. [100] Ohta, H., Yatomi, Y., Sweeney, E.A., Hakomori, S., Igarashi, Y., A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-alpha in human neutrophils. FEBS Lett. 355 (1994), 267–270.
101. [101] Sweeney, E.A., Inokuchi, J., Igarashi, Y., Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide. FEBS Lett. 425 (1998), 61–65.
102. [102] Cuvillier, O., Edsall, L., Spiegel, S., Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J. Biol. Chem. 275 (2000), 15691–15700.
103. [103] Cuvillier, O., Nava, V.E., Murthy, S.K., Edsall, L.C., Levade, T., Milstien, S., Spiegel, S., Sphingosine generation, cytochrome c release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells. Cell Death Differ. 8 (2001), 162–171.
104. [104] Hannun, Y.A., Bell, R.M., Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235 (1987), 670–674.
105. [105] Hamaguchi, A., Suzuki, E., Murayama, K., Fujimura, T., Hikita, T., Iwabuchi, K., Handa, K., Withers, D.A., Masters, S.C., Fu, H., Hakomori, S., Sphingosine-dependent protein kinase-1, directed to 14-3-3, is identified as the kinase domain of protein kinase C delta. J. Biol. Chem. 278 (2003), 41557–41565.
106. [106] Hung, W.C., Chang, H.C., Chuang, L.Y., Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem. J. 338:Pt 1 (1999), 161–166.
107. [107] Maceyka, M., Harikumar, K.B., Milstien, S., Spiegel, S., Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 22 (2012), 50–60.
108. [108] Liu, H., Toman, R.E., Goparaju, S.K., Maceyka, M., Nava, V.E., Sankala, H., Payne, S.G., Bektas, M., Ishii, I., Chun, J., Milstien, S., Spiegel, S., Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J. Biol. Chem. 278 (2003), 40330–40336.
109. [109] Taha, T.A., Kitatani, K., El-Alwani, M., Bielawski, J., Hannun, Y.A., Obeid, L.M., Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis. FASEB J. 20 (2006), 482–484.
110. [110] Chipuk, J.E., McStay, G.P., Bharti, A., Kuwana, T., Clarke, C.J., Siskind, L.J., Obeid, L.M., Green, D.R., Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148 (2012), 988–1000.
111. [111] Scherz-Shouval, R., Elazar, Z., ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 17 (2007), 422–427.
112. [112] Tanida, I., Ueno, T., Kominami, E., LC3 conjugation system in mammalian autophagy. Int. J. Biochem. Cell Biol. 36 (2004), 2503–2518.
113. [113] Thumm, M., Structure and function of the yeast vacuole and its role in autophagy. Microsc. Res. Tech. 51 (2000), 563–572.
114. [114] Hemelaar, J., Lelyveld, V.S., Kessler, B.M., Ploegh, H.L., A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L. J. Biol. Chem. 278 (2003), 51841–51850.
115. [115] Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., Yoshimori, T., LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19 (2000), 5720–5728.
116. [116] Tanida, I., Ueno, T., Kominami, E., Human light chain 3/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes. J. Biol. Chem. 279 (2004), 47704–47710.
117. [117] Lemasters, J.J., Variants of mitochondrial autophagy: Types 1 and 2 mitophagy and micromitophagy (Type 3). Redox Biol. 2 (2014), 749–754.
118. [118] Sentelle, R.D., Senkal, C.E., Jiang, W., Ponnusamy, S., Gencer, S., Selvam, S.P., Ramshesh, V.K., Peterson, Y.K., Lemasters, J.J., Szulc, Z.M., Bielawski, J., Ogretmen, B., Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nat. Chem. Biol. 8 (2012), 831–838.
119. [119] Jiang, W., Ogretmen, B., Ceramide stress in survival versus lethal autophagy paradox: ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Autophagy 9 (2013), 258–259.
120. [120] Bienias, K., Fiedorowicz, A., Sadowska, A., Prokopiuk, S., Car, H., Regulation of sphingomyelin metabolism. Pharmacol. Rep. 68 (2016), 570–581.
121. [121] Ayasolla, K., Khan, M., Singh, A.K., Singh, I., Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic. Biol. Med. 37 (2004), 325–338.
122. [122] Grimm, M.O., Grimm, H.S., Patzold, A.J., Zinser, E.G., Halonen, R., Duering, M., Tschape, J.A., De Strooper, B., Muller, U., Shen, J., Hartmann, T., Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat. Cell Biol. 7 (2005), 1118–1123.
123. [123] Beresewicz, A., Dobrzyn, A., Gorski, J., Accumulation of specific ceramides in ischemic/reperfused rat heart; effect of ischemic preconditioning. J. Physiol. Pharmacol. 53 (2002), 371–382.
124. [124] Zhang, D.X., Fryer, R.M., Hsu, A.K., Zou, A.P., Gross, G.J., Campbell, W.B., Li, P.L., Production and metabolism of ceramide in normal and ischemic-reperfused myocardium of rats. Basic Res. Cardiol. 96 (2001), 267–274.
125. [125] Novgorodov, S.A., Gudz, T.I., Ceramide and mitochondria in ischemic brain injury. Int. J. Biochem. Mol. Biol. 2 (2011), 347–361.
126. [126] Galadari, S., Rahman, A., Pallichankandy, S., Galadari, A., Thayyullathil, F., Role of ceramide in diabetes mellitus: evidence and mechanisms. Lipids Health Dis., 12, 2013, 98.
127. [127] Lang, F., Ullrich, S., Gulbins, E., Ceramide formation as a target in beta-cell survival and function. Expert Opin. Ther. Targets 15 (2011), 1061–1071.
128. [128] Welsh, N., Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J. Biol. Chem. 271 (1996), 8307–8312.
129. [129] Ishizuka, H., Watanabe, M., Kubota, T., Matsuzaki, S.W., Otani, Y., Kitajima, M., Antitumor activity of murine monoclonal antibody NCC-ST-421 on human cancer cells by inducing apoptosis. Anticancer Res. 18 (1998), 2513–2518.
130. [130] Liadis, N., Salmena, L., Kwan, E., Tajmir, P., Schroer, S.A., Radziszewska, A., Li, X., Sheu, L., Eweida, M., Xu, S., Gaisano, H.Y., Hakem, R., Woo, M., Distinct in vivo roles of caspase-8 in beta-cells in physiological and diabetes models. Diabetes 56 (2007), 2302–2311.
131. [131] Shimabukuro, M., Zhou, Y.T., Levi, M., Unger, R.H., Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 2498–2502.
132. [132] Lupi, R., Dotta, F., Marselli, L., Del Guerra, S., Masini, M., Santangelo, C., Patane, G., Boggi, U., Piro, S., Anello, M., Bergamini, E., Mosca, F., Di Mario, U., Del Prato, S., Marchetti, P., Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51 (2002), 1437–1442.
133. [133] Oskouian, B., Saba, J.D., Cancer treatment strategies targeting sphingolipid metabolism. Adv. Exp. Med. Biol. 688 (2010), 185–205.
134. [134] Adada, M., Luberto, C., Canals, D., Inhibitors of the sphingomyelin cycle: sphingomyelin synthases and sphingomyelinases. Chem. Phys. Lipids 197 (2016), 45–59.
135. [135] Liu, Y.Y., Yu, J.Y., Yin, D., Patwardhan, G.A., Gupta, V., Hirabayashi, Y., Holleran, W.M., Giuliano, A.E., Jazwinski, S.M., Gouaze-Andersson, V., Consoli, D.P., Cabot, M.C., A role for ceramide in driving cancer cell resistance to doxorubicin. FASEB J. 22 (2008), 2541–2551.
136. [136] Min, J., Mesika, A., Sivaguru, M., Van Veldhoven, P.P., Alexander, H., Futerman, A.H., Alexander, S., (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. Mol. Cancer Res. 5 (2007), 801–812.
137. [137] White-Gilbertson, S., Mullen, T., Senkal, C., Lu, P., Ogretmen, B., Obeid, L., Voelkel-Johnson, C., Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28 (2009), 1132–1141.
138. [138] Ponnusamy, S., Meyers-Needham, M., Senkal, C.E., Saddoughi, S.A., Sentelle, D., Selvam, S.P., Salas, A., Ogretmen, B., Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncol. 6 (2010), 1603–1624.
139. [139] Koybasi, S., Senkal, C.E., Sundararaj, K., Spassieva, S., Bielawski, J., Osta, W., Day, T.A., Jiang, J.C., Jazwinski, S.M., Hannun, Y.A., Obeid, L.M., Ogretmen, B., Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem. 279 (2004), 44311–44319.
140. [140] Senkal, C.E., Ponnusamy, S., Bielawski, J., Hannun, Y.A., Ogretmen, B., Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways. FASEB J. 24 (2010), 296–308.
141. [141] Heffernan-Stroud, L.A., Obeid, L.M., Sphingosine kinase 1 in cancer. Adv. Cancer Res. 117 (2013), 201–235.
142. [142] Kunkel, G.T., Maceyka, M., Milstien, S., Spiegel, S., Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat. Rev. Drug Discov. 12 (2013), 688–702.
143. [143] Pyne, N.J., Pyne, S., Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 10 (2010), 489–503.
144. [144] Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y.A., Obeid, L.M., Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23 (2009), 405–414.
145. [145] Nava, V.E., Hobson, J.P., Murthy, S., Milstien, S., Spiegel, S., Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp. Cell Res. 281 (2002), 115–127.
146. [146] Guan, H., Song, L., Cai, J., Huang, Y., Wu, J., Yuan, J., Li, J., Li, M., Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells. PLoS One, 6, 2011, e19946.
147. [147] Salama, M.F., Carroll, B., Adada, M., Pulkoski-Gross, M., Hannun, Y.A., Obeid, L.M., A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma. FASEB J. 29 (2015), 2803–2813.
148. [148] Adada, M.M., Canals, D., Jeong, N., Kelkar, A.D., Hernandez-Corbacho, M., Pulkoski-Gross, M.J., Donaldson, J.C., Hannun, Y.A., Obeid, L.M., Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion. FASEB J. 29 (2015), 4654–4669.